Tablets & Capsules


Issue link:

Contents of this Issue


Page 25 of 67

24 October 2019 Tablets & Capsules S Fritz-Martin Scholz Bosch Packaging Technology Overcoming the challenges of continuous solid oral dosage manufacturing continuous manufacturing Increasingly, pharmaceutical production plants must be effi- cient and user friendly. They must also meet industry demand for shorter development times with minimal active pharmaceuti- cal ingredient (API) usage and direct transfer from development to production without scale-up, as well as flexible batch sizes and integrated quality monitoring. This article discusses how continuous manufacturing technologies can help drug product manufacturers meet these requirements. olid oral dosage forms (SODFs), including tablets, capsules, and sachets, make up roughly 60 percent of the total pharmaceutical products market. Despite the development of new liquid biologics and parenteral medi- cations, SODFs will continue to play an important role in the global pharmaceutical market in the future. Increasing pressure to reduce costs and improve prod- uct quality is driving companies to adopt more efficient, modular, and flexible manufacturing processes. The

Articles in this issue

Archives of this issue

view archives of Tablets & Capsules - TC1019